1. Ischaemic stroke on anticoagulation therapy and early recurrence in acute cardioembolic stroke: the IAC study
- Author
-
M. Edip Gurol, Karen L. Furie, Iman Moeini-Naghani, Angela Liu, Tushar Trivedi, Eva Mistry, Adam de Havenon, Daniyal Asad, Salah G. Keyrouz, Heather Martin, Ava L. Liberman, Kiersten Espaillat, Khadean Moncrieffe, Jose Tan, Ashutosh Kaushal, Erica Scher, Idrees Azher, Natalie Cheng, Charles Esenwa, Muhammad Nagy, Mithilesh Siddu, Brian Mac Grory, James A Giles, Manivannan Veerasamy, Hemanth Pasupuleti, Muhib Khan, Christopher R. Leon Guerrero, Amre Nouh, Shadi Yaghi, Eric E. Smith, Hiba Fakhri, and Nils Henninger
- Subjects
Male ,medicine.medical_specialty ,Early Recurrence ,030204 cardiovascular system & hematology ,03 medical and health sciences ,0302 clinical medicine ,Recurrence ,Internal medicine ,Atrial Fibrillation ,Ischaemic stroke ,Secondary Prevention ,Humans ,Medicine ,Stroke ,Event risk ,Aged ,Ischemic Stroke ,Aged, 80 and over ,Embolic Stroke ,Cardioembolic stroke ,business.industry ,Proportional hazards model ,Anticoagulants ,Atrial fibrillation ,medicine.disease ,Psychiatry and Mental health ,Stroke prevention ,Cardiology ,Female ,Surgery ,Neurology (clinical) ,business ,Risk Reduction Behavior ,030217 neurology & neurosurgery - Abstract
Background and purposeA subset of ischaemic stroke patients with atrial fibrillation (AF) have ischaemic stroke despite anticoagulation. We sought to determine the association between prestroke anticoagulant therapy and recurrent ischaemic events and symptomatic intracranial haemorrhage (sICH).MethodsWe included consecutive patients with acute ischaemic stroke and AF from the Initiation of Anticoagulation after Cardioembolic stroke (IAC) study from eight comprehensive stroke centres in the USA. We compared recurrent ischaemic events and delayed sICH risk using adjusted Cox regression analyses between patients who were prescribed anticoagulation (ACp) versus patients who were naïve to anticoagulation therapy prior to the ischaemic stroke (anticoagulation naïve).ResultsAmong 2084 patients in IAC, 1518 had prior anticoagulation status recorded and were followed for 90 days. In adjusted Cox hazard models, ACp was associated with some evidence of a higher risk higher risk of 90-day recurrent ischaemic events only in the fully adjusted model (adjusted HR 1.50, 95% CI 0.99 to 2.28, p=0.058) but not increased risk of 90-day sICH (adjusted HR 1.08, 95% CI 0.46 to 2.51, p=0.862). In addition, switching anticoagulation class was not associated with reduced risk of recurrent ischaemic events (adjusted HR 0.41, 95% CI 0.12 to 1.33, p=0.136) nor sICH (adjusted HR 1.47, 95% CI 0.29 to 7.50, p=0.641).ConclusionAF patients with ischaemic stroke despite anticoagulation may have higher recurrent ischaemic event risk compared with anticoagulation-naïve patients. This suggests differing underlying pathomechanisms requiring different stroke prevention measures and identifying these mechanisms may improve secondary prevention strategies.
- Published
- 2021